Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced

Lin Li1,2, Reiner Ulrich3,4, Wolfgang Baumgärtner5,6

  • 1Department of Pathology, University of Veterinary Medicine Hannover, Bünteweg 17, 30559, Hannover, Germany. Lin.Li@tiho-hannover.de.

Abstract

Insights

Resistant mice show high interferon-stimulated gene (ISG) protein levels, like ISG15 and PKR, crucial for controlling Theiler's murine encephalomyelitis virus (TMEV) infection and preventing demyelinating disease.

Area of Science:

  • Neuroimmunology
  • Virology
  • Infectious Diseases

Background:

  • Theiler's murine encephalomyelitis virus (TMEV) infection in mice models human multiple sclerosis.
  • TMEV causes biphasic disease (acute polioencephalomyelitis and chronic demyelinating leukomyelitis) in susceptible strains.
  • Resistant mice clear TMEV via innate immunity, including type I interferon (IFN) pathway activation.

Purpose of the Study:

  • Investigate the role of the type I interferon (IFN) pathway in TMEV-induced demyelinating disease (TMEV-IDD).
  • Analyze gene and protein expression of key interferon-stimulated genes (ISGs) like ISG15, PKR, and OAS in susceptible and resistant mice.

Main Methods:

  • Microarray analysis of spinal cord tissue from TMEV-infected SJL/J mice.
  • Real-time PCR, immunohistochemistry, and immunofluorescence to assess ISG expression in SJL/J and C57BL/6 mice.
  • Comparison of ISG protein levels in mock- and TMEV-infected mice during acute and chronic phases.

Main Results:

  • Despite increased ISG gene expression in susceptible SJL/J mice, protein expression was impaired and localized to lesions.
  • Resistant C57BL/6 mice exhibited high ISG protein levels (ISG15, PKR) in spinal cord gray and white matter.
  • ISG15 localized to astrocytes and endothelial cells; PKR was found in microglia/macrophages, oligodendrocytes, and neurons.

Conclusions:

  • High ISG15 and PKR protein levels in resistant mice likely inhibit TMEV replication.
  • These antiviral proteins may be critical for resistance to TMEV-induced demyelinating disease.